Remdesivir, the drug being used to treat President Trump for COVID-19, was developed at UAB several years ago under a federal drug-discovery grant. The drug proved tried as a method to fight Ebola but proved ineffective. In the spring, scientists tested it against the novel coronavirus, and it showed early positive results. It was approved for use in hospitalized patients being treated for COVID-19. The president was given his second dose of the five-day remdesivir protocol on Saturday.
Read the story BirminghamWatch wrote about the drug when it began to show promise this spring.
UAB Drug Remdesivir Is First to Block the COVID-19 Virus, May Become Standard of Care. Fauci “Optimistic.”